Skip to content

Stereotaxis STXS Stock-Based Comp

Stock-Based Comp at other companies

Abbott logo
AbbottABT
$317M+9.7%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%
Medtronic logo
MedtronicMDT
$95M+6.7%
Stryker logo
StrykerSYK
$87M+3.6%
ITG
Integer HoldingsITGR
$6.66M-3.2%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$8.96M-1.3%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's stock-based comp?
Stereotaxis (STXS) reported stock-based comp of $2.11M in Q1 2026.
How has Stereotaxis's stock-based comp changed year-over-year?
Stereotaxis's stock-based comp decreased by 16.8% year-over-year, from $2.54M to $2.11M.
What is the long-term trend for Stereotaxis's stock-based comp?
Over 4 years (2021 to 2025), Stereotaxis's stock-based comp has grown at a 1.3% compound annual growth rate (CAGR), from $9.36M to $9.85M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.